Inmunobiología linfocitaria
Centro de Investigación Biomédica en Red sobre Enfermedades Hepáticas y Digestivas
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Centro de Investigación Biomédica en Red sobre Enfermedades Hepáticas y Digestivas (52)
2024
-
Anti-miR-873-5p improves alcohol-related liver disease by enhancing hepatic deacetylation via SIRT1
JHEP Reports, Vol. 6, Núm. 1
-
Breaking the barriers: the role of gut homeostasis in Metabolic-Associated Steatotic Liver Disease (MASLD)
Gut Microbes, Vol. 16, Núm. 1
-
Cirrhosis-downregulated LSECtin can be retrieved by cytokines, shifts the TLR-induced LSECs secretome and correlates with the hepatic Th response
Liver International, Vol. 44, Núm. 4, pp. 996-1010
-
Curcumin encapsulated in milk small extracellular vesicles as a nanotherapeutic alternative in experimental chronic liver disease
Biomedicine and Pharmacotherapy, Vol. 173
-
Inhibition of ALK3-mediated signalling pathway protects against acetaminophen-induced liver injury
Redox Biology, Vol. 71
-
Roadmap to DILI research in Europe. A proposal from COST action ProEuroDILINet
Pharmacological Research, Vol. 200
-
p63 controls metabolic activation of hepatic stellate cells and fibrosis via an HER2-ACC1 pathway
Cell Reports Medicine, Vol. 5, Núm. 2
2023
-
A Novel Mouse Model of Combined Hepatocellular-Cholangiocarcinoma Induced by Diethylnitrosamine and Loss of Ppp2r5d
Cancers, Vol. 15, Núm. 16
-
Advancing with cancer immunotherapeutics: CD29+ regulatory T cell antagonism
Gut
-
Expression of HMGCS2 in intestinal epithelial cells is downregulated in inflammatory bowel disease associated with endoplasmic reticulum stress
Frontiers in immunology, Vol. 14, pp. 1185517
-
Hepatocyte dedifferentiation profiling in alcohol-related liver disease identifies CXCR4 as a driver of cell reprogramming
Journal of Hepatology, Vol. 79, Núm. 3, pp. 728-740
-
JNKs protect from cholestatic liver disease progression by modulating Apelin signalling
JHEP Reports, Vol. 5, Núm. 11
-
Lack of Cyclin E1 in hepatocytes aggravates ethanol-induced liver injury and hepatic steatosis in experimental murine model of acute and chronic alcohol-associated liver disease
Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1869, Núm. 4
-
Neuroblastoma RAS viral oncogene homolog (N-RAS) deficiency aggravates liver injury and fibrosis
Cell death & disease, Vol. 14, Núm. 8, pp. 514
-
Novel therapeutic avenues for the study of chronic liver disease and regeneration: The foundation of the Iberoamerican Consortium for the study of liver Cirrhosis
Gastroenterologia y Hepatologia
-
Obesity under the moonlight of c-MYC
Frontiers in Cell and Developmental Biology, Vol. 11
-
Role of EpCAM+ CD133+ extracellular vesicles in steatosis to steatohepatitis transition in NAFLD
Liver International, Vol. 43, Núm. 9, pp. 1909-1919
-
The outcome of boosting mitochondrial activity in alcohol-associated liver disease is organ-dependent
Hepatology (Baltimore, Md.), Vol. 78, Núm. 3, pp. 878-895
-
Tumor progression locus 2 (TPL2): A Cot-plicated progression from inflammation to chronic liver disease
Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1869, Núm. 4
2022
-
A Potential Role for Bile Acid Signaling in Celiac Disease-Associated Fatty Liver
Metabolites, Vol. 12, Núm. 2